For me I am happy to have a partner on a ROW deal and for the company to continue on their other projects unhindered as Neuren. (standalone)
Retts P3 should yield better outcomes than P2 from all accounts based the data.
The share price is what it is right now, investors pay multiples on the business plan looking forward, it is not hard to see more than double or triple the current price if an investor wants a a sizable stake and such a stake cannot be obtained on market without driving the price up even more. Even looking at today's market depth, the shares are very much tightly held and if you intended on owning 200,000 shares you couldn't buy them without driving the price to $3.50+
For me I am happy to have a partner on a ROW deal and for the...
-
- There are more pages in this discussion • 428 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B | |||
| Open | High | Low | Value | Volume |
| $20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 249 | $20.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.31 | 790 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |